Goldman Sachs’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,285
| Closed | -$4.64K | – | 5241 |
|
|
2023
Q1 | $4.64K | Sell |
1,285
-282
| -18% | -$1.02K | ﹤0.01% | 5013 |
|
|
2022
Q4 | $50.5K | Sell |
1,567
-136
| -8% | -$4.38K | ﹤0.01% | 4790 |
|
|
2022
Q3 | $71K | Sell |
1,703
-399
| -19% | -$16.6K | ﹤0.01% | 4992 |
|
|
2022
Q2 | $89K | Sell |
2,102
-596
| -22% | -$25.2K | ﹤0.01% | 5152 |
|
|
2022
Q1 | $183K | Buy |
2,698
+205
| +8% | +$13.9K | ﹤0.01% | 5130 |
|
|
2021
Q4 | $302K | Buy |
2,493
+568
| +30% | +$68.8K | ﹤0.01% | 4776 |
|
|
2021
Q3 | $271K | Buy |
1,925
+586
| +44% | +$82.5K | ﹤0.01% | 4717 |
|
|
2021
Q2 | $368K | Buy |
1,339
+636
| +90% | +$175K | ﹤0.01% | 4593 |
|
|
2021
Q1 | $150K | Buy |
703
+142
| +25% | +$30.3K | ﹤0.01% | 4934 |
|
|
2020
Q4 | $136K | Buy |
561
+51
| +10% | +$12.4K | ﹤0.01% | 4409 |
|
|
2020
Q3 | $54K | Buy |
+510
| New | +$54K | ﹤0.01% | 4322 |
|
|
2019
Q3 | – | Sell |
-13,482
| Closed | -$2.42M | – | 4362 |
|
|
2019
Q2 | $2.42M | Sell |
13,482
-9
| -0.1% | -$1.62K | ﹤0.01% | 2705 |
|
|
2019
Q1 | $2.16M | Sell |
13,491
-786
| -6% | -$126K | ﹤0.01% | 2908 |
|
|
2018
Q4 | $3.72M | Sell |
14,277
-1,421
| -9% | -$370K | ﹤0.01% | 2509 |
|
|
2018
Q3 | $3.82M | Sell |
15,698
-1,140
| -7% | -$278K | ﹤0.01% | 2571 |
|
|
2018
Q2 | $3.97M | Buy |
+16,838
| New | +$3.97M | ﹤0.01% | 2520 |
|